MAPT and Alzheimer disease: Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and neuropathological changes including aggregation of extracellular amyloid-β (Aβ) plaques and intracellular tau neurofibrillary tangles.